Evotec stock gains 9.51 percent ahead of November 5 results
Published on 10/25/2026 at 17:21 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSWeekly balance and next session
- Evotec recorded a 9.51 percent weekly gain in the company topic coverage dated October 24, 2026.
- Evotec stock trades in weekend trading at Lang & Schwarz at EUR 2.81 at 5:19 p.m. CEST on October 25, 2026, unchanged versus the Xetra close of October 23, 2026.
- The next Xetra session is scheduled for October 26, 2026.
Evotec stock gained 9.51 percent over the week ahead of results scheduled for November 5, 2026, according to the Evotec topic coverage. The weekly balance is separate from the current weekend quote.
Market context: Market report DAX.
The week in figures
Lang & Schwarz quoted Evotec at EUR 2.81 in weekend trading at 5:19 p.m. CEST on October 25, 2026. The price was unchanged versus the Xetra close of EUR 2.81 on October 23, 2026. The topic coverage recorded a 9.51 percent weekly gain.
The further course of weekend trading at Lang & Schwarz until 7:00 p.m. CET/CEST is shown by the continuously updated real-time quote of Evotec stock.
Chronology of the week
The company topic coverage listed preliminary nine-month revenue of EUR 465.0 million for October 13, 2026. It also listed Evotec's appointment of Joanna Holbrook as chief scientific officer on October 15, 2026, with the appointment effective November 1, 2026.
On October 21, 2026, the coverage cited RBC's EUR 10.00 price target. On October 23, 2026, it cited Berenberg's EUR 3.60 target. The coverage on October 24, 2026, pointed to November 5, 2026, for the results.
Dates of the coming week
The next Xetra session is scheduled for October 26, 2026. Evotec's third-quarter and nine-month results are scheduled for publication on November 5, 2026, according to the Evotec topic coverage.
